Patents by Inventor Craig Baysinger
Craig Baysinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10188862Abstract: A method and system is described for ensuring a state of an active implantable medical device based on the presence and persistence of a magnetic field. The output of a magnetic field sensor is monitored. The active implantable medical device is maintained in a first state, for so long as the presence of a magnetic field is detected by the magnetic field sensor, until a first interval is surpassed. If the first interval is surpassed, then a determination is made as to whether a second interval has been surpassed. If it is determined that the second interval has not been surpassed, then the active implantable medical device is transitioned into a second state. If it is determined that the second interval has been surpassed, then it is ensured that the active implantable medical device is in a predetermined one of the first and second states.Type: GrantFiled: September 6, 2016Date of Patent: January 29, 2019Assignee: NeuroPace, Inc.Inventors: Brett Wingeier, Barbara Gibb, Craig Baysinger, Thomas Tcheng, Suresh Gurunathan
-
Publication number: 20160375247Abstract: A method and system is described for ensuring a state of an active implantable medical device based on the presence and persistence of a magnetic field. The output of a magnetic field sensor is monitored. The active implantable medical device is maintained in a first state, for so long as the presence of a magnetic field is detected by the magnetic field sensor, until a first interval is surpassed. If the first interval is surpassed, then a determination is made as to whether a second interval has been surpassed. If it is determined that the second interval has not been surpassed, then the active implantable medical device is transitioned into a second state. If it is determined that the second interval has been surpassed, then it is ensured that the active implantable medical device is in a predetermined one of the first and second states.Type: ApplicationFiled: September 6, 2016Publication date: December 29, 2016Inventors: Brett WINGEIER, Barbara GIBB, Craig BAYSINGER, Thomas TCHENG, Suresh GURUNATHAN
-
Patent number: 9463322Abstract: A method and system is described for ensuring a state of an active implantable medical device based on the presence and persistence of a magnetic field. The output of a magnetic field sensor is monitored. The active implantable medical device is maintained in a first state, for so long as the presence of a magnetic field is detected by the magnetic field sensor, until a first interval is surpassed. If the first interval is surpassed, then a determination is made as to whether a second interval has been surpassed. If it is determined that the second interval has not been surpassed, then the active implantable medical device is transitioned into a second state. If it is determined that the second interval has been surpassed, then it is ensured that the active implantable medical device is in a predetermined one of the first and second states.Type: GrantFiled: April 21, 2016Date of Patent: October 11, 2016Assignee: NeuroPace, Inc.Inventors: Brett Wingeier, Barbara Gibb, Craig Baysinger, Thomas Tcheng, Suresh Gurunathan
-
Patent number: 9421380Abstract: A system and method for automatically adjusting the value of a parameter defined to manage and control the resources recruited by an implantable medical device to supply power or the device to deliver an instance of an electrical stimulation therapy to a patient. In embodiments, the parameter corresponds to a number of capacitors the discharge of which supplies the power to deliver a stimulation therapy at a programmed amplitude. Whenever the circumstances prevent the programmed amplitude from being delivered, the system and method automatically adjust the resource-controlling parameter to use the minimum power to achieve the desired (programmed) amplitude or as close as possible to that programmed amplitude. Some embodiments additionally include using another parameter (a equivalent amplitude parameter) to balance the charge delivered through multiple pathways in parallel sourced from a single reservoir of power.Type: GrantFiled: July 1, 2015Date of Patent: August 23, 2016Assignee: NeuroPace, Inc.Inventors: Brett D Wingeier, Suresh Gurunathan, Craig Baysinger
-
Publication number: 20160235991Abstract: A method and system is described for ensuring a state of an active implantable medical device based on the presence and persistence of a magnetic field. The output of a magnetic field sensor is monitored. The active implantable medical device is maintained in a first state, for so long as the presence of a magnetic field is detected by the magnetic field sensor, until a first interval is surpassed. If the first interval is surpassed, then a determination is made as to whether a second interval has been surpassed. If it is determined that the second interval has not been surpassed, then the active implantable medical device is transitioned into a second state. If it is determined that the second interval has been surpassed, then it is ensured that the active implantable medical device is in a predetermined one of the first and second states.Type: ApplicationFiled: April 21, 2016Publication date: August 18, 2016Inventors: Brett WINGEIER, Barbara GIBB, Craig BAYSINGER, Thomas TCHENG, Suresh GURUNATHAN
-
Patent number: 9345884Abstract: A method and system is described for ensuring a state of an active implantable medical device based on the presence and persistence of a magnetic field. The output of a magnetic field sensor is monitored. The active implantable medical device is maintained in a first state, for so long as the presence of a magnetic field is detected by the magnetic field sensor, until a first interval is surpassed. If the first interval is surpassed, then a determination is made as to whether a second interval has been surpassed. If it is determined that the second interval has not been surpassed, then the active implantable medical device is transitioned into a second state. If it is determined that the second interval has been surpassed, then it is ensured that the active implantable medical device is in a predetermined one of the first and second states.Type: GrantFiled: September 28, 2012Date of Patent: May 24, 2016Assignee: NeuroPace, Inc.Inventors: Brett Wingeier, Barbara Gibb, Craig Baysinger, Thomas Tcheng, Suresh Gurunathan
-
Publication number: 20150297896Abstract: A system and method for automatically adjusting the value of a parameter defined to manage and control the resources recruited by an implantable medical device to supply power or the device to deliver an instance of an electrical stimulation therapy to a patient. In embodiments, the parameter corresponds to a number of capacitors the discharge of which supplies the power to deliver a stimulation therapy at a programmed amplitude. Whenever the circumstances prevent the programmed amplitude from being delivered, the system and method automatically adjust the resource-controlling parameter to use the minimum power to achieve the desired (programmed) amplitude or as close as possible to that programmed amplitude. Some embodiments additionally include using another parameter (a equivalent amplitude parameter) to balance the charge delivered through multiple pathways in parallel sourced from a single reservoir of power.Type: ApplicationFiled: July 1, 2015Publication date: October 22, 2015Inventors: Brett D. WINGEIER, Suresh GURUNATHAN, Craig BAYSINGER
-
Patent number: 9101771Abstract: A system and method for automatically adjusting the value of a parameter defined to manage and control the resources recruited by an implantable medical device to supply power or the device to deliver an instance of an electrical stimulation therapy to a patient. In embodiments, the parameter corresponds to a number of capacitors the discharge of which supplies the power to deliver a stimulation therapy at a programmed amplitude. Whenever the circumstances prevent the programmed amplitude from being delivered, the system and method automatically adjust the resource-controlling parameter to use the minimum power to achieve the desired (programmed) amplitude or as close as possible to that programmed amplitude. Some embodiments additionally include using another parameter (a equivalent amplitude parameter) to balance the charge delivered through multiple pathways in parallel sourced from a single reservoir of power.Type: GrantFiled: March 14, 2014Date of Patent: August 11, 2015Assignee: NeuroPace, Inc.Inventors: Brett D Wingeier, Suresh Gurunathan, Craig Baysinger
-
Publication number: 20140277289Abstract: A system and method for automatically adjusting the value of a parameter defined to manage and control the resources recruited by an implantable medical device to supply power or the device to deliver an instance of an electrical stimulation therapy to a patient. In embodiments, the parameter corresponds to a number of capacitors the discharge of which supplies the power to deliver a stimulation therapy at a programmed amplitude. Whenever the circumstances prevent the programmed amplitude from being delivered, the system and method automatically adjust the resource-controlling parameter to use the minimum power to achieve the desired (programmed) amplitude or as close as possible to that programmed amplitude. Some embodiments additionally include using another parameter (a equivalent amplitude parameter) to balance the charge delivered through multiple pathways in parallel sourced from a single reservoir of power.Type: ApplicationFiled: March 14, 2014Publication date: September 18, 2014Applicant: NeuroPace, Inc.Inventors: Brett D. WINGEIER, Suresh GURUNATHAN, Craig BAYSINGER
-
Publication number: 20140094876Abstract: A method and system is described for ensuring a state of an active implantable medical device based on the presence and persistence of a magnetic field. The output of a magnetic field sensor is monitored. The active implantable medical device is maintained in a first state, for so long as the presence of a magnetic field is detected by the magnetic field sensor, until a first interval is surpassed. If the first interval is surpassed, then a determination is made as to whether a second interval has been surpassed. If it is determined that the second interval has not been surpassed, then the active implantable medical device is transitioned into a second state. If it is determined that the second interval has been surpassed, then it is ensured that the active implantable medical device is in a predetermined one of the first and second states.Type: ApplicationFiled: September 28, 2012Publication date: April 3, 2014Applicant: NeuroPace, Inc.Inventors: Brett Wingeier, Barbara Gibb, Craig Baysinger, Thomas Tcheng, Suresh Gurunathan
-
Publication number: 20030004428Abstract: A system and method for detecting and predicting neurological events with an implantable device uses a relatively low-power central processing unit in connection with signal processing circuitry to identify features (including half waves) and calculate window-based characteristics (including line lengths and areas under the curve of the waveform) in an electrographic signal received from a patient's brain. The features and window-based characteristics are combinable in various ways according to the invention to detect and predict neurological events in real time, enabling responsive action by the implantable device.Type: ApplicationFiled: June 28, 2001Publication date: January 2, 2003Inventors: Benjamin D. Pless, Stephen T. Archer, Craig Baysinger, Barbara Gibb, Suresh K. Gurunathan, Bruce Kirkpatrick, Thomas K. Tcheng